Gibbs Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Gibbs Wealth Management's NVS Position: Q1 2026 in Review
Gibbs Wealth Management increased its Novartis (NVS) stake by 332% in Q1 2026, buying an estimated $1.62M and bringing the position to 13,783 shares worth $2.11M. The position accounts for 0.28% of the portfolio, ranked #64.
Gibbs Wealth Management first reported a position in NVS in Q4 2024 and has held it in 6 quarters since. 1,604 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Gibbs Wealth Management held 13,783 shares of Novartis worth $2.11M as of Q1 2026.
- Gibbs Wealth Management bought 10,592 Novartis shares in Q1 2026, an estimated $1.62M.
- Novartis made up 0.28% of Gibbs Wealth Management's portfolio in Q1 2026, its #64 holding.
- Gibbs Wealth Management first reported a position in Novartis in Q4 2024 and has held it in 6 quarters since.
- 1,604 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.